Many patients with prostate cancer are treated with drugs that lower or block hormones that fuel tumor growth. While the drugs are effective for a time, most patients eventually develop resistance to these therapies. A new study from Washington University School of Medicine in St. Louis has ident...
treatmentGlobally, prostate cancer (PC) is a leading cause of death in men. Although androgen deprivation therapy (ADT) is the cornerstone of treatment for the disease, most patients eventually develop castration‐resistant PC (CRPC). Patients with non﹎etastatic (nm) CRPC, the earliest ...
Nanobodies: a tool to open new horizons in diagnosis and treatment of prostate cancerNanobodyVHHProstate cancerPSMAPSAProstate cancer is one of the most ... M Hosseindokht,H Bakherad,H Zare - 《Cancer Cell International》 被引量: 0发表: 2021年 Integrated chronostratigraphic calibration of the...
Traditional Chinese medicine and pharmacy in the treatment of prostate cancer field is in the initial stage.It has great potential and prospects for development in improving the quality of life of patients,delaying tumor metastasis and progression.In this paper,traditional Chinese medicine treatment of...
Genome-wide association studies (GWAS) have identified ~170 genetic loci associated with prostate cancer (PCa) risk, but most of them were identified in European populations. We here performed a GWAS and replication study using a large Japanese cohort (9
None of them received any prior treatment when the tumor and matched normal samples were collected. All the samples were subject to WGS, wherein 155 were under additional WGBS and RNA sequencing. The detailed process for sample collection, DNA/RNA extraction, library preparation, sequencing, and ...
WEDNESDAY, Sept. 29, 2021 (HealthDay News) -- A pair of experimental tests could help doctors detect colon or prostate cancer with just a sample of blood or saliva. One test examines a person's blood for four biomarkers linked to inflammation. In a small study, it outperformed the fecal...
Interleukin-15 (IL-15) is a cytokine previously suggested as a potential immunotherapy for cancer treatment. IL-15 can effectively reduce tumor growth in many preclinical tumor models including prostate cancer. This is due to its ability to expand and activate immune cells, such as CD8+T cells...
Expanding treatment options for metastatic prostate cancer. BACKGROUND Locomotor training, including the use of body-weight support in treadmill stepping, is a physical therapy intervention used to improve recovery ... ES Antonarakis,MA Eisenberger - 《New England Journal of Medicine》 被引量: 130...
There are currently no effective treatments for NEPC, with estimates up to 15% of men may develop this aggressive subtype of prostate cancer after hormonal treatment—a major problem because these men face "very poor outcomes". "By revealing another regulator of prostate cancer cell plasticity that...